The company will use the funds for a European feasibility study for its transcatheter device and for the launch of a ...

Four complex heart surgeries were done without a single chest cut using TPVR Read ahead to know how this minimally invasive ...

The agency’s decision supports broader access to a minimally invasive treatment for patients with severe tricuspid ...

RATES of permanent pacemaker implantation (PPI) exceed 20% in patients with aortic regurgitation (AR). A new retrospective ...

Pacific TMVR market. The sector’s expansion is attributed to rising disease prevalence, technological progress, demand for ...

Transcatheter aortic valve implantation (TAVI) is now an established treatment option for elderly patients with severe ...

The findings highlight the importance of having an EP versed in lead management on the heart valve team, one expert says.

Depending on procedure, the transfemoral, segment dominated the market in 2020, and this trend is expected to continue during ...

Overview of Prosthetic Heart Valve MarketThe Global Prosthetic Heart Valve Market is valued at USD 8.74 Billion in 2024 and is projected to attain a value of USD 28.96 Billion by 2035 at a CAGR of 11.

Edwards Lifesciences announced the FDA approved its transcatheter aortic valve replacement platform for treatment of severe asymptomatic aortic stenosis, the first in this patient population ...

Israeli clinical stage medical company Restore Medical, which is developing transcatheter therapies for heart failure, has ...